Skip to main content
Clinical Trials/NCT00932581
NCT00932581
Completed
Not Applicable

Investigation of the Psychometric Properties of the Bradykinesia Subscale When Administered Alone Versus as a Component of the Entire Motor Examination Section of the Unified Parkinson's Disease Rating Scale

Teva Branded Pharmaceutical Products R&D, Inc.0 sites110 target enrollmentJune 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Parkinson's Disease
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Enrollment
110
Primary Endpoint
Scores on the UPDRS motor evaluation subscale are equivalent.
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The purpose of this study is to examine whether scores on questionnaires that rate how much Parkinson's Disease (PD) has slowed movements of the body differ when the order of the questions are changed. The consistency and accuracy of the questionnaires will also be examined. It is hypothesized that there will not be a difference.

Registry
clinicaltrials.gov
Start Date
June 2009
End Date
December 2009
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Male or Female at least 30 years of age
  • Willing to be assessed using the motor examination section of the UPDRS and the SPES/SCOPA motor evaluation
  • Patients must be willing and able to give written informed consent prior to performing an study procedures
  • Be in the "ON" State (only for patients who fluctuate between "ON" and "OFF" states)

Exclusion Criteria

  • Absence of bradykinesia at the time of assessment
  • Hoehn and Yahr stage not available from patient's chart or not assessed between 3 and 180 days prior to clinic visit
  • Has received and experimental drug within the last thirty (30) days

Outcomes

Primary Outcomes

Scores on the UPDRS motor evaluation subscale are equivalent.

Time Frame: 4 months

Secondary Outcomes

  • Correlations between the UPDRS motor examination bradykinesis subscale and the remaining UPDRS motor examination items, Hoeh and Yahr stage, Schwab and England scale, and SPES/SCOPA motor evaluation.(4 months)

Similar Trials